Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma

Autor: Naren L. Banik, Ron Ron Cheng, William A. Vandergrift, Megan L.T. Hilbert, Scott Lindhorst, Sunil J. Patel, Michele L Decandio, Pierre Giglio, Abhay K. Varma, Arabinda Das, David Cachia, Yaenette N. Dixon-Moh

Publikováno v: Cancer Growth and Metastasis, Vol 2015, Iss 8, Pp 51-60 (2015)
Cancer Growth and Metastasis, Vol 8 (2015)
Cancer Growth and Metastasis

Glioblastoma (GB) is the most common malignant brain tumor. Drug resistance frequently develops in these tumors during chemotherapy. Therefore, predicting drug response in these patients remains a major challenge in the clinic. Thus, to improve the c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::643a7831997df8448b7600a1360cade8
http://www.la-press.com/synergistic-effects-of-crizotinib-and-temozolomide-in-experimental-fig-article-a5237